Cargando…

Anti-EBOV GP IgGs Lacking α1-3-Galactose and Neu5Gc Prolong Survival and Decrease Blood Viral Load in EBOV-Infected Guinea Pigs

Polyclonal xenogenic IgGs, although having been used in the prevention and cure of severe infectious diseases, are highly immunogenic, which may restrict their usage in new applications such as Ebola hemorrhagic fever. IgG glycans display powerful xenogeneic antigens in humans, for example α1–3 Gala...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reynard, Olivier, Jacquot, Frédéric, Evanno, Gwénaëlle, Mai, Hoa Le, Salama, Apolline, Martinet, Bernard, Duvaux, Odile, Bach, Jean-Marie, Conchon, Sophie, Judor, Jean-Paul, Perota, Andrea, Lagutina, Irina, Duchi, Roberto, Lazzari, Giovanna, Le Berre, Ludmilla, Perreault, Hélène, Lheriteau, Elsa, Raoul, Hervé, Volchkov, Viktor, Galli, Cesare, Soulillou, Jean-Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4900587/ https://www.ncbi.nlm.nih.gov/pubmed/27280712 http://dx.doi.org/10.1371/journal.pone.0156775

Ejemplares similares

LIS1, a glyco-humanized swine polyclonal anti-lymphocyte globulin, as a novel induction treatment in solid organ transplantation
por: Rousse, Juliette, et al.
Publicado: (2023)

Ebola virus (EBOV) infection: Therapeutic strategies
por: De Clercq, Erik
Publicado: (2015)

Phylogenetic Analysis of Guinea 2014 EBOV Ebolavirus Outbreak
por: Dudas, Gytis, et al.
Publicado: (2014)

Antiviral Innate Responses Induced by VSV-EBOV Vaccination Contribute to Rapid Protection
por: Menicucci, Andrea R., et al.
Publicado: (2019)

Generation of cattle knockout for galactose‐α1,3‐galactose and N‐glycolylneuraminic acid antigens
por: Perota, Andrea, et al.
Publicado: (2019)

Clock Rooting Further Demonstrates that Guinea 2014 EBOV is a Member of the Zaïre Lineage
por: Calvignac-Spencer, Sébastien, et al.
Publicado: (2014)

Estimating the Reproduction Number of Ebola Virus (EBOV) During the 2014 Outbreak in West Africa
por: Althaus, Christian L.
Publicado: (2014)

Ebolavirus is evolving but not changing: No evidence for functional change in EBOV from 1976 to the 2014 outbreak
por: Olabode, Abayomi S., et al.
Publicado: (2015)

Systematic Genome-wide Screening and Prediction of microRNAs in EBOV During the 2014 Ebolavirus Outbreak
por: Teng, Yue, et al.
Publicado: (2015)

Intradermal Immunization of EBOV VLPs in Guinea Pigs Induces Broader Antibody Responses Against GP Than Intramuscular Injection
por: Liu, Ying, et al.
Publicado: (2020)

Development and Evaluation of a Rapid and Sensitive EBOV-RPA Test for Rapid Diagnosis of Ebola Virus Disease
por: Yang, Mingjuan, et al.
Publicado: (2016)

To B or Not to B: Mechanisms of Protection Conferred by rVSV-EBOV-GP and the Roles of Innate and Adaptive Immunity
por: Pinski, Amanda N., et al.
Publicado: (2020)

Single low-dose VSV-EBOV vaccination protects cynomolgus macaques from lethal Ebola challenge
por: Marzi, Andrea, et al.
Publicado: (2019)

The rVSV-EBOV vaccine provides limited cross-protection against Sudan virus in guinea pigs
por: Cao, Wenguang, et al.
Publicado: (2023)

Development of an EBOV MiniG plus system as an advanced tool for anti-Ebola virus drug screening
por: Hsu, Chi-Ju, et al.
Publicado: (2023)

Intradermal immunization by Ebola virus GP subunit vaccines using microneedle patches protects mice against lethal EBOV challenge
por: Liu, Ying, et al.
Publicado: (2018)

Usp18 Expression in CD169(+) Macrophages is Important for Strong Immune Response after Vaccination with VSV-EBOV
por: Friedrich, Sarah-Kim, et al.
Publicado: (2020)

The transcriptomic profiling of SARS-CoV-2 compared to SARS, MERS, EBOV, and H1N1
por: Alsamman, Alsamman M., et al.
Publicado: (2020)

Identification of promising anti-EBOV inhibitors: de novo drug design, molecular docking and molecular dynamics studies
por: Mohamed, Eslam A. R., et al.
Publicado: (2022)

Structural Transition and Antibody Binding of EBOV GP and ZIKV E Proteins from Pre-Fusion to Fusion-Initiation State
por: Lappala, Anna, et al.
Publicado: (2018)

Transcriptomic analysis reveals a previously unknown role for CD8(+) T-cells in rVSV-EBOV mediated protection
por: Menicucci, Andrea R., et al.
Publicado: (2017)

Author Correction: Intradermal immunization by Ebola virus GP subunit vaccines using microneedle patches protects mice against lethal EBOV challenge
por: Liu, Ying, et al.
Publicado: (2023)

Quantification of Viral and Host Biomarkers in the Liver of Rhesus Macaques: A Longitudinal Study of Zaire Ebolavirus Strain Kikwit (EBOV/Kik)
por: Greenberg, Alexandra, et al.
Publicado: (2020)

The anti-HCV, Sofosbuvir, versus the anti-EBOV Remdesivir against SARS-CoV-2 RNA dependent RNA polymerase in silico
por: Elfiky, Abdo A., et al.
Publicado: (2021)

N-Glycolylneuraminic Acid (Neu5Gc) Null Large Animals by Targeting the CMP-Neu5Gc Hydroxylase (CMAH)
por: Perota, Andrea, et al.
Publicado: (2019)

Sector-by-sector analysis of dependence dynamics between global large-cap companies and infectious diseases: A time-varying copula approach in EBOV and COVID-19 episodes
por: Ghaemi Asl, Mahdi, et al.
Publicado: (2021)

Characterization of the therapeutic effect of antibodies targeting the Ebola glycoprotein using a novel BSL2-compliant rVSVΔG-EBOV-GP infection model
por: Lee, Ha-Na, et al.
Publicado: (2021)

Flexible docking-based molecular dynamics simulation of natural product compounds and Ebola virus Nucleocapsid (EBOV NP): a computational approach to discover new drug for combating Ebola
por: Nasution, Mochammad Arfin Fardiansyah, et al.
Publicado: (2018)

Monitoring Viral Entry in Real-Time Using a Luciferase Recombinant Vesicular Stomatitis Virus Producing SARS-CoV-2, EBOV, LASV, CHIKV, and VSV Glycoproteins
por: Lay Mendoza, Maria Fernanda, et al.
Publicado: (2020)

Challenging the Role of Diet-Induced Anti-Neu5Gc Antibodies in Human Pathologies
por: Soulillou, Jean-Paul, et al.
Publicado: (2020)

Editorial: Human Antibodies Against the Dietary Non-human Neu5Gc-Carrying Glycans in Normal and Pathologic States
por: Soulillou, Jean-Paul, et al.
Publicado: (2020)

Glycan microarray reveal induced IgGs repertoire shift against a dietary carbohydrate in response to rabbit anti-human thymocyte therapy
por: Amon, Ron, et al.
Publicado: (2017)

No Increase in Colon Cancer Risk Following Induction with Neu5Gc-Bearing Rabbit Anti-T Cell IgG (ATG) in Recipients of Kidney Transplants
por: Soulillou, Jean-Paul, et al.
Publicado: (2018)

XAV-19, a Swine Glyco-Humanized Polyclonal Antibody Against SARS-CoV-2 Spike Receptor-Binding Domain, Targets Multiple Epitopes and Broadly Neutralizes Variants
por: Vanhove, Bernard, et al.
Publicado: (2021)

Corrigendum: XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2 spike receptor-binding domain, targets multiple epitopes and broadly neutralizes variants
por: Vanhove, Bernard, et al.
Publicado: (2023)

Corrigendum: Broad Impairment of Natural Killer Cells From Operationally Tolerant Kidney Transplanted Patients
por: Dugast, Emilie, et al.
Publicado: (2018)

Broad Impairment of Natural Killer Cells From Operationally Tolerant Kidney Transplanted Patients
por: Dugast, Emilie, et al.
Publicado: (2017)

The Immunogenicity of the Tumor-Associated Antigen α-Fetoprotein Is Enhanced by a Fusion with a Transmembrane Domain
por: Tran, Lucile, et al.
Publicado: (2012)

Multiscale fluorescent tracking of immune cells in the liver with a highly biocompatible far-red emitting polymer probe
por: Daniel, Malo, et al.
Publicado: (2020)

Screening of Lactobacillus spp. for the prevention of Pseudomonas aeruginosa pulmonary infections
por: Alexandre, Youenn, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_jnbdhp4hq9m32i20jcqsjv3ufs